189 related articles for article (PubMed ID: 34379461)
1. Prevention and management of moisture-associated skin damage.
Voegeli D; Hillery S
Br J Nurs; 2021 Aug; 30(15):S40-S46. PubMed ID: 34379461
[TBL] [Abstract][Full Text] [Related]
2. Moisture-associated skin damage: causes and an overview of assessment, classification and management.
Parnham A; Copson D; Loban T
Br J Nurs; 2020 Jun; 29(12):S30-S37. PubMed ID: 32579457
[TBL] [Abstract][Full Text] [Related]
3. Moisture-associated skin damage: overview and pathophysiology.
Gray M; Black JM; Baharestani MM; Bliss DZ; Colwell JC; Goldberg M; Kennedy-Evans KL; Logan S; Ratliff CR
J Wound Ostomy Continence Nurs; 2011; 38(3):233-41. PubMed ID: 21490547
[TBL] [Abstract][Full Text] [Related]
4. Incidence of moisture-associated skin damage in an intensive care unit.
Valls-Matarín J; Del Cotillo-Fuente M; Ribal-Prior R; Pujol-Vila M; Sandalinas-Mulero I
Enferm Intensiva; 2017; 28(1):13-20. PubMed ID: 28110903
[TBL] [Abstract][Full Text] [Related]
5. An economic evaluation of four skin damage prevention regimens in nursing home residents with incontinence: economics of skin damage prevention.
Bliss DZ; Zehrer C; Savik K; Smith G; Hedblom E
J Wound Ostomy Continence Nurs; 2007; 34(2):143-52; discussion 152. PubMed ID: 17413828
[TBL] [Abstract][Full Text] [Related]
6. A decade of research on Incontinence-Associated Dermatitis (IAD): Evidence, knowledge gaps and next steps.
Beeckman D
J Tissue Viability; 2017 Feb; 26(1):47-56. PubMed ID: 26949126
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness of a hydrocolloid crusting method versus standard care in the treatment of incontinence-associated dermatitis among adult patients in an acute care setting: A randomised controlled trial.
Gunasegaran N; Ang SY; Ng YZ; Lee NES; Agus N; Lee CW; Ong CE; Mostafa SS; Aloweni F
J Tissue Viability; 2023 May; 32(2):171-178. PubMed ID: 36717288
[TBL] [Abstract][Full Text] [Related]
8. Moisture-associated skin damage: cause, risk and management.
Lumbers M
Br J Nurs; 2018 Jun; 27(Sup12):S6-S14. PubMed ID: 29944429
[TBL] [Abstract][Full Text] [Related]
9. MASD part 2: incontinence-associated dermatitis and intertriginous dermatitis: a consensus.
Black JM; Gray M; Bliss DZ; Kennedy-Evans KL; Logan S; Baharestani MM; Colwell JC; Goldberg M; Ratliff CR
J Wound Ostomy Continence Nurs; 2011; 38(4):359-70; quiz 371-2. PubMed ID: 21747256
[TBL] [Abstract][Full Text] [Related]
10. Moisture-associated skin damage (MASD): A best practice recommendation from Wund-D.A.CH.
Dissemond J; Assenheimer B; Gerber V; Hintner M; Puntigam MJ; Kolbig N; Koller S; Kurz P; Läuchli S; Probst S; Protz K; Steiniger A; Strohal R; Traber J; Kottner J
J Dtsch Dermatol Ges; 2021 Jun; 19(6):815-825. PubMed ID: 33942514
[TBL] [Abstract][Full Text] [Related]
11. Incontinence-associated dermatitis: new insights into an old problem.
Voegeli D
Br J Nurs; 2016 Mar 10-23; 25(5):256, 258, 260-2. PubMed ID: 26972998
[TBL] [Abstract][Full Text] [Related]
12. Does skin care frequency affect the severity of incontinence-associated dermatitis in critically ill patients?
Conley P; McKinsey D; Ross O; Ramsey A; Feeback J
Nursing; 2014 Dec; 44(12):27-32. PubMed ID: 25406780
[TBL] [Abstract][Full Text] [Related]
13. Management of incontinence-associated dermatitis with a skin barrier protectant.
Southgate G; Bradbury S
Br J Nurs; 2016 May 12-25; 25(9):S20-9. PubMed ID: 27172503
[TBL] [Abstract][Full Text] [Related]
14. Prevention and management of incontinence-associated dermatitis.
Nix D; Haugen V
Drugs Aging; 2010 Jun; 27(6):491-6. PubMed ID: 20524708
[TBL] [Abstract][Full Text] [Related]
15. Comparing the effectiveness and wash-off resistance of skin barrier creams: a healthy volunteer study.
Dykes P; Bradbury S
J Wound Care; 2017 Sep; 26(9):552-557. PubMed ID: 28880764
[TBL] [Abstract][Full Text] [Related]
16. Management of incontinence-associated dermatitis patients using a skin protectant in acute care: a case series.
Acton C; Ivins N; Bainbridge P; Browning P
J Wound Care; 2020 Jan; 29(1):18-26. PubMed ID: 31930942
[TBL] [Abstract][Full Text] [Related]
17. Incontinence-related skin damage: essential knowledge.
Gray M
Ostomy Wound Manage; 2007 Dec; 53(12):28-32. PubMed ID: 18184980
[TBL] [Abstract][Full Text] [Related]
18. Optimal management of incontinence-associated dermatitis in the elderly.
Gray M
Am J Clin Dermatol; 2010; 11(3):201-10. PubMed ID: 20131923
[TBL] [Abstract][Full Text] [Related]
19. Incontinence-associated dermatitis: reducing adverse events.
Rippon M; Colegrave M; Ousey K
Br J Nurs; 2016 Oct; 25(18):1016-1021. PubMed ID: 27734729
[TBL] [Abstract][Full Text] [Related]
20. Independent risk factors for the development of incontinence-associated dermatitis (category 2) in critically ill patients with fecal incontinence: A cross-sectional observational study in 48 ICU units.
Van Damme N; Clays E; Verhaeghe S; Van Hecke A; Beeckman D
Int J Nurs Stud; 2018 May; 81():30-39. PubMed ID: 29428583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
